Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Immunotech Laborator (EM) IMMB

Healthcare Biotechnology
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as... see more

Current News (EXPM:IMMB)

Eco Petroleum-ECPO Completes Acquisition of Immunotherapy Drug Development Company

Marketwired June 14, 2017

Immunotech Laboratories, Inc. Announces Successful Completion of Phase III Testing of the Patented Immune Therapeutic Vaccine -1

Filing Services Canada January 25, 2017

Immunotech Laboratories, Inc. Enters into Agreement to Market Potential Ebola Virus Disease ("EVD") Treatment and Implement Strategy for Company's ITV-1 Infectious Diseases Treatment in Africa

Business Wire October 21, 2014

Immunotech Laboratories, Inc. Enters into Negotiations with Uldic Investment Pvt. Ltd. for Market Development

Filing Services Canada October 9, 2014

Immunotech Laboratories, Inc. Updates Progress on Negotiations for Phase III Testing on its Treatments for HIV/AIDS and Hepatitis C Viruses in Macedonia and Serbia

Business Wire October 7, 2014

Immunotech Laboratories, Inc. Updates Progress on Negotiations for Phase III Testing on its Treatments for HIV/AIDS and Hepatitis C Viruses in Macedonia and Serbia

Filing Services Canada October 7, 2014

Immunotech Laboratories, Inc. Announces Successful Completion of Phase I and Phase II Field Trials of the Company's Patented Treatment of the HIV/AIDS and Hepatitis C Viruses

Business Wire August 28, 2014

Immunotech Laboratories Inc. Corporate Update

ACCESS Newswire January 10, 2014

Immunotech Laboratories, Inc. Announces the Results From Gap Analysis Report

Globe Newswire June 19, 2013
View More News ››

Opinion & Analysis (EXPM:IMMB)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:IMMB)

Be the first to post on this bullboard.

Grizzly Discoveries Inc

Grizzly Discoveries Inc

Grizzly Discoveries Inc. engages in the acquisition, exploration, and development of precious and base metals properties ...
View More »

Podcasts